Novo Nordisk and OpenAI forge alliance to drive speedy drug development

April 14, 2026

Pharmaceutical Technology

Novo Nordisk inks this deal with OpenAI as the total value of AI partnerships took a 120% YoY uptick between 2024 and 2025.